The impact of tovorafenib on tumor growth was assessed in two different NF1-LOF mutant models, including an NF1-LOF mutant ERMS PDX model and an NF1-LOF melanoma xenograft tumor model, MeWo. Here, NF1 is linked to neoplasm.